STATEMENT: The U.S. House of Representatives Should Pass H.R. 3, Transformative Legislation To Lower the Cost of Prescription Drugs
Washington, D.C. — Yesterday, Speaker Nancy Pelosi (D-CA) announced that the U.S. House of Representatives will vote next week on H.R. 3, the Lower Drug Costs Now Act, a bill that would empower Medicare to negotiate prescription drug prices and make those lower prices available to both Medicare beneficiaries and those with private insurance. Topher Spiro, vice president for Health Policy and a senior fellow at the Center for American Progress, released this statement following the announcement:
The announcement of a floor vote tees up what would be the most transformative piece of legislation to lower the price of prescription drugs to pass a chamber of Congress in a generation.
Nearly 9 in 10 Americans support empowering Medicare to negotiate drug prices, and for years, President Donald Trump has promised to do just that. Now he’s signaled his opposition to legislation that would make it happen. President Trump may not be willing to keep his promise, but the House of Representatives should keep its promise by passing H.R. 3 and delivering for the people.
For more information on this topic or to speak with an expert, please contact Colin Seeberger at email@example.com or 202-741-6292.